Ask AI
ProCE Banner Series

Live Workshop Series—Immune Checkpoint Inhibitors in BCC and CSCC: Aligning Clinical Practice With Best Practices and Guidelines

Register now for this interactive, case-based workshop series to learn more about the biologic rationale for the use of immune checkpoint inhibitors in the treatment of patients with BCC and CSCC, optimal management of immune-related adverse events, and potential utility of investigational immune checkpoint inhibitor–based strategies for patients with BCC and CSCC. After the meeting, download the associated slideset for use in your clinic.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for oncologists, dermatologists, advanced practice providers, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with basal cell carcinoma and cutaneous squamous cell carcinoma.

All Events

Live Workshop Series—Immune Checkpoint Inhibitors in BCC and CSCC: Aligning Clinical Practice With Best Practices and Guidelines

Upcoming Events

June

17

2026

7:00 PM - 8:00 PM Central Time (CT)

Virtual

Topics

Basal Cell Carcinoma and  Cutaneous Squamous Cell Carcinoma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in effectively using immune checkpoint inhibitors to improve outcomes in patients with basal cell carcinoma and cutaneous squamous cell carcinoma.

Target Audience
This activity is intended for oncologists, dermatologists, advanced practice providers, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with basal cell carcinoma and cutaneous squamous cell carcinoma.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Educate patients with BCC and CSCC on the risks and benefits of immune checkpoint inhibitor therapy
  • Integrate immune checkpoint inhibitors into treatment plans for appropriate patients with BCC and CSCC, considering clinical data and expert recommendations along with patient goals and perspectives
  • Evaluate the potential clinical impact of novel intralesional and perioperative immune checkpoint inhibitor therapies under investigation for patients with BCC and CSCC
  • Manage immune-related adverse events promptly in patients with BCC and CSCC who are receiving immune checkpoint inhibitor therapy

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191